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Abstract
Shigella flexneri is historically regarded as the primary agent of bacillary dysentery, yet the
closely-related Shigella sonnei is replacing S. flexneri, especially in developing countries.
The underlying reasons for this dramatic shift are mostly unknown. Using a zebrafish (Danio
rerio) model of Shigella infection, we discover that S. sonnei is more virulent than S. flexneri
in vivo. Whole animal dual-RNAseq and testing of bacterial mutants suggest that S. sonnei
virulence depends on its O-antigen oligosaccharide (which is unique among Shigella spe-
cies). We show in vivo using zebrafish and ex vivo using human neutrophils that S. sonnei
O-antigen can mediate neutrophil tolerance. Consistent with this, we demonstrate that O-
antigen enables S. sonnei to resist phagolysosome acidification and promotes neutrophil
cell death. Chemical inhibition or promotion of phagolysosome maturation respectively
decreases and increases neutrophil control of S. sonnei and zebrafish survival. Strikingly,
larvae primed with a sublethal dose of S. sonnei are protected against a secondary lethal
dose of S. sonnei in an O-antigen-dependent manner, indicating that exposure to O-antigen
can train the innate immune system against S. sonnei. Collectively, these findings reveal
O-antigen as an important therapeutic target against bacillary dysentery, and may explain
the rapidly increasing S. sonnei burden in developing countries.
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Author summary
Shigella sonnei is predominantly responsible for dysentery in developed countries, and is
replacing Shigella flexneri in areas undergoing economic development and improvements
in water quality. Using Shigella infection of zebrafish (in vivo) and human neutrophils (in
vitro), we discover that S. sonnei is more virulent than S. flexneri because of neutrophil tol-
erance mediated by its O-antigen oligosaccharide acquired from the environmental bacte-
ria Plesiomonas shigelloides. To inspire new approaches for S. sonnei control, we show that
increased phagolysosomal acidification or innate immune training can promote S. sonnei
clearance by neutrophils in vivo. These findings have major implications for our evolu-
tionary understanding of Shigella, and may explain why exposure to P. shigelloides in low
and middle-income countries (LMICs) can protect against dysentery incidence.
Introduction
Shigella is the causative agent of bacillary dysentery (also called shigellosis), resulting from
invasion of the intestinal epithelium and leading to ~164000 deaths annually [1,2]. The Global
Enteric Multicenter Study (GEMS) is the largest study ever conducted on diarrhoeal diseases
in developing countries (i.e. areas undergoing economic development and improvements in
water quality), enrolling > 20000 children from seven countries across Asia and Africa, and
identified Shigella as a major cause of diarrhoea in children < 5 years old [3]. Shigella is also
recognised by the World Health Organization as a priority pathogen exhibiting antimicrobial
resistance [4,5]. The emergence of multidrug resistant bacteria and the lack of effective vac-
cines has resulted in a desperate need to understand Shigella pathogenesis and identify new
approaches for infection control. In the lab, infection with Shigella flexneri has been a valuable
discovery tool in the field of innate immunity, helping to illuminate the role of neutrophil
extracellular traps (NETs) [6], nucleotide-binding oligomerisation domain (NOD)-like recep-
tors (NLRs) [7], bacterial autophagy [8], interferon-inducible guanylate-binding proteins
(GBPs) [9,10] and septin-mediated cell-autonomous immunity [11,12] in host defence.
The genus Shigella comprises four different species (S. flexneri, S. sonnei, S. boydii, S. dysen-
teriae), although DNA sequencing suggests they evolved from convergent evolution of differ-
ent founders [13]. The most recent strains of S. flexneri emerged from Escherichia coli>35000
years ago [13], while S. sonnei (a monoclonal strain) emerged from E. coli in central Europe
~500 years ago [14]. S. flexneri is historically regarded as the primary agent of dysentery world-
wide, yet S. sonnei has recently become the most prevalent cause of dysentery in developing
countries [15,16]. Reasons for this dramatic shift are mostly unknown. Hypotheses include
improved water sanitisation leading to reduced cross-immunisation by Plesiomonas shigel-
loides (which carries an O-antigen oligosaccharide identical to S. sonnei) [16,17], as well as a
type VI secretion system (T6SS)-mediated competitive advantage that S. sonnei exerts over S.
flexneri and the Gram-negative gut microbiome for niche occupancy [18].
Except for non-human primates, there is no mammalian model that fully recapitulates
human shigellosis. The zebrafish model is increasingly being used to study human bacterial
pathogens in vivo, including S. flexneri [19,20]. The major pathogenic events that lead to shig-
ellosis in humans (i.e., macrophage cell death, invasion and multiplication within epithelial
cells, cell-to-cell spread, inflammatory destruction of the host epithelium) are recapitulated in
a zebrafish model of S. flexneri infection [21]. Exploiting the optical accessibility of zebrafish
larvae, it is possible to spatio-temporally examine the development, coordination and resolu-
tion of the innate immune response to S. flexneri in vivo. As a result, S. flexneri-zebrafish
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infection has been useful to illuminate key roles for bacterial autophagy [22], bacterial preda-
tion [23], inflammation [24] and trained innate immunity [25] in host defence in vivo.
How S. sonnei infection differs from S. flexneri infection is poorly understood, yet clinical
management of both infections is the same. Here, we develop a S. sonnei-zebrafish infection
model and discover that S. sonnei is more virulent than S. flexneri in vivo because of neutrophil
tolerance mediated by its O-antigen. We show that increased phagolysosomal acidification or
innate immune training can promote S. sonnei clearance by neutrophils in vivo. These results
may inspire new approaches for S. sonnei control.
Results
S. sonnei is more virulent than S. flexneri in a zebrafish infection model
To compare the virulence of S. flexneri and S. sonnei in vivo, we injected S. flexneri M90T or S.
sonnei 53G in the hindbrain ventricle (HBV) of zebrafish larvae at 3 days post-fertilisation
(dpf). Unexpectedly, S. sonnei led to significantly more zebrafish death and higher bacterial
burden, as compared to S. flexneri (Fig 1A and 1B). The majority of larvae inoculated with
<600 CFU of S. sonnei survive, whereas the majority of larvae inoculated with>1500 CFU of
S. sonnei die by 72 hpi (S1A and S1B Fig). In agreement with being more virulent, S. sonnei
infected larvae have significantly increased expression of key inflammatory markers at 6 and
24 hpi, as compared to S. flexneri infected larvae (Fig 1C and 1D). Moreover, S. sonnei, unlike
S. flexneri, disseminates out of the HBV into the neuronal tube and bloodstream (Fig 1E and
1F, S1C–S1F Fig). The increased virulence of S. sonnei is also observed using an intravenous
route of infection (S1G and S1H Fig), using human clinical isolates of bacteria (S1I and S1J
Fig) and when infected larvae are incubated at 28.5˚C, 32.5˚C or 37˚C (Fig 1A and 1B, S1K–
S1N Fig). Therefore, we used S. sonnei 53G infection of the HBV incubated at 28.5˚C (the
standard temperature for zebrafish maintenance) for the rest of our study (unless specified
otherwise). Taken together, using multiple infection routes, bacterial strains and temperatures,
these data show for the first time that S. sonnei is significantly more virulent than S. flexneri in
vivo.
Whole animal dual-RNAseq profiling of S. sonnei infected larvae
The transcriptional signature of Shigella in vivo was mostly unknown. We performed whole
animal dual-RNAseq profiling of S. sonnei infected larvae by isolating whole RNA at 24 hpi
and mapping reads to both Shigella and zebrafish genomes (Fig 2A). RNA isolated from Log
phase (OD600 ~0.6) bacterial culture grown at 28.5˚C was used as baseline for the identification
of differential expression in the bacterial transcriptome. RNA isolated from PBS-injected lar-
vae was used as baseline for the identification of differential expression in the host transcrip-
tome. Gene count data was obtained for both the host and pathogen, and statistical analysis
was performed using DESeq2 (see dedicated section in Materials and Methods). Genes were
considered significantly differentially expressed if Log2(Fold Change) > 1 or < -1 and the
adjusted p value < 0.05. Principal component analysis (PCA) was employed for S. sonnei and
larval count data separately, and these plots confirm the clustering between biological repli-
cates according to their state (S2A and S2B Fig). After performing differential expression anal-
ysis between infected and control states, we found 1538 differentially expressed S. sonnei genes
(representing ~1/3 of the S. sonnei 53G genome, Fig 2B, see also S1 Table and S2 Fig for in-
depth exploration) and 337 differentially expressed zebrafish genes (Fig 2C, see also S2 Table
and S2 Fig for in-depth exploration). In the case of S. sonnei, 878 genes are significantly upre-
gulated, including genes involved in resistance to stress (i.e. adaptation to acidic environment,
metabolism, ion homeostasis; Fig 2D, see also S2E, S2G and S2J Fig and S1 Table). In the
S. sonnei O-antigen and dysentery incidence
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case of S. sonnei-infected larvae, 283 host genes are significantly upregulated, including inflam-
matory markers previously tested by qRT-PCR (Fig 1C and 1D) and other genes involved in
Fig 1. S. sonnei is more virulent than S. flexneri in a zebrafish infection model. A,B. S. sonnei is more virulent than S. flexneri in vivo. Survival curves (A) and Log10-
transformed CFU counts (B) of larvae injected in the hindbrain ventricle (HBV) with PBS (grey), S. flexneri (blue) or S. sonnei (red). Experiments are cumulative of 3
biological replicates. In B, full symbols represent live larvae and empty symbols represent larvae that at the plating timepoint had died within the last 16 hours. Statistics:
Log-rank (Mantel-Cox) test (A); unpaired t-test on Log10-transformed values (B);
��p<0.0021; ���p<0.0002; ����p< 0.0001. C,D. S. sonnei elicits a stronger
inflammatory signature than S. flexneri in vivo. Quantitative real time PCR for representative inflammatory markers were performed on pools of 20 HBV injected
larvae collected at 6 (C) or 24 (D) hpi with PBS (grey), S. flexneri (blue) or S. sonnei (red). Experiments are cumulative of 4 biological replicates. Statistics: one-way
ANOVA with Sidak’s correction on Log2-transformed values; ns, non-significant;
�p<0.0332 ��p<0.0021; ���p<0.0002; ����p<0.0001. E,F. S. sonnei can disseminate
from the injection site. Representative images of three GFP-labelled S. flexneri-infected (E) or S. sonnei-infected (F) larvae at 24 hpi. In D, arrows indicate
dissemination in the blood circulation; arrowheads indicate dissemination in the neuronal tube. Scale bars = 1 mm.
https://doi.org/10.1371/journal.ppat.1008006.g001
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innate immune signalling, granulopoiesis/neutrophil chemotaxis and inflammation (Fig 2E, see
also S2F, S2H, S2I and S2K Fig and S2 Table). Consistent with this, enrichment analysis for
DNA regulatory elements identified the statistical overrepresentation of immune-related tran-
scription factor binding sites (i.e. Rel/Rela, Nfkb2, Stats, Cepbg, Jun, Spi1; S2 Table). Together,
whole animal dual-RNAseq profiling identified novel markers of S. sonnei infection and zebra-
fish host defence, and we generated an open-access resource for their in-depth exploration. Raw
sequencing data are deposited in GEO, the NCBI repository (accession: GSE140544).
S. sonnei virulence depends on its O-antigen
S. sonnei encodes a T6SS and capsule which have been linked to virulence in the murine and
rabbit intestine model, respectively (S3A and S3B Fig) [18,26]. However, when larvae are
infected with a T6SS (Δtssb) or capsule (Δg4c) deficient strain, virulence is not significantly
reduced as compared to wildtype (WT) bacteria (S3C and S3D Fig). We next infected larvae
with a phase II S. sonnei strain which lacks the pSS virulence plasmid (-pSS S. sonnei). Here,
~100% of larvae survive infection (Fig 3A and 3B). Consistent with a role in virulence, the S.
sonnei pSS plasmid (which is unstable and frequently lost in culture [27]) is retained during
zebrafish infection at 28.5˚C (S3E Fig). The S. sonnei pSS encodes a type III secretion system
(T3SS) and the biosynthesis machinery for an O-antigen oligosaccharide (O-Ag) non-homolo-
gous to those encoded by other Shigella species (S3F Fig) [28]. Strikingly, infection with O-Ag
deficient (ΔO-Ag) S. sonnei fully recapitulates results obtained with S. sonnei -pSS, while infec-
tion with T3SS deficient S. sonnei (Δmxid) demonstrates only partial loss of virulence (Fig 3A–
3D, S3G Fig). Experiments performed at 32.5˚C demonstrate that ΔO-Ag S. sonnei remain
avirulent at higher temperatures (S3H–S3K Fig), and that T3SS-mediated virulence of S. son-
nei is temperature dependent (Fig 3A and 3B, S3J and S3K Fig). Consistent with a role for
O-Ag in S. sonnei virulence, dual-RNAseq profiling identified wzzB/SSON53G_RS12230 (a
protein involved in the extension of O-Ag oligosaccharide chains) as significantly upregulated
(Log2(FC) = 1.31, padj = 3.31�10
−25) during zebrafish infection (S3L Fig). To address whether
Fig 2. Whole animal dual-RNAseq profiling of S. sonnei infected larvae. A. Workflow for dual-RNAseq processing. 3 dpf larvae were infected with
~7000 CFU of S. sonnei. Pools of infected larvae were collected for RNA isolation at 24 hpi. As a control for the bacterial transcriptome, the same
cultures of S. sonnei were diluted 50x and subcultured at 28.5˚C (same temperature at which infected larvae are maintained) until Log phase (OD600
~0.6) was reached. As a control for the zebrafish transcriptome, pools of PBS-injected larvae at 24 hpi were used. Reads from infected larvae were
mapped separately to both the S. sonnei and zebrafish genomes, while reads from S. sonnei in vitro cultures and PBS injected larvae were mapped to the
pathogen or host genome, respectively. B,C. Volcano plots for bacterial and zebrafish genes during S. sonnei infection. Each datapoint refers to a
single gene. Non significantly differentially expressed genes are shown in grey, while significantly downregulated genes are shown in blue and
significantly upregulated genes are shown in red. Plot in B refers to S. sonnei genes and plot in C refers to zebrafish genes. See also S2 Fig for additional
details. Log2(FC) and -Log10(padj) coordinates were derived from data analysis with the DESeq2 package in R. In B, points enclosed in the black
rectangle were computed to have a DESeq2 padj = 0. D,E. Heatmap of the top 50 differentially expressed bacterial and zebrafish genes during S.
sonnei infection. Columns represent individual biological replicates (R1, R2, R3). Heatmaps were created from counts per million (CPM) reads values,
using “pheatmap” package in R. Shades of blue indicate downregulation and shades of red indicate upregulation compared to baseline. Plot in D refers
to S. sonnei genes and plot in E refers to zebrafish genes. From top to bottom, genes represented in D are: adhE_3, glyA, purF, purD, purL,
SSON53G_RS25460 (treB-like), gcvP, gcvH, yjiY, gcvT, treC, SSON53G_RS05440 (ymdF-like), gadC, SSON53G_RS20945 (slp-like), otsA,
SSON53G_RS02230 (bolA-like), suhB, katE, SSON53G_RS31575 (mcbA-like), hdeD, gadB_1, gadB_2, yohC, gadE, hdeB, SSON53G_RS09595 (narU-
like), yegP, ycgB, hdeA, SSON53G_RS20815 (yhiM-like), fadB, yafH, fadA, dadA, artJ, argC, ygjG, argI, yjbJ, aceA, narZ, trxC, aceB_1, argA, modA,
ybaT, ybaA, modB, phoH, rmf. From top to bottom, genes represented in E are: krtt1c19e, si:dkey-183i3.5 (thread biopolymer filament subunit alpha-
like), zgc:136930 (thread biopolymer filament subunit gamma-like), cyt1, cyt1l, irg1l, si:ch211-153b23.4 (YrdC domain-containing protein-like), si:
ch211-153b23.5, timp2b, mmp13a, junbb, tnfaip2b, noxo1a, zgc:111983 (mucin-like), c4b, c3a.1, mpeg1.2, si:ch211-39f2.3 (tecta-like), socs3b,
tmem176l.4, zgc:174917 (phytanoyl-CoA dioxygenase domain-containing protein 1-like), lgals1l1, cebpb, mmp9, si:ch211-15b10.6 (tifa-like), fosl2,
moxd1, cbln11, lect2l, cfb, steap4, irf1b, il1b, si:ch211-183d5.2 (nedd8-like), atf3, cxcl8a, si:dkey-33c14.3 (uncharacterised lincRNA), cxcl18b,
cr926130.2 (uncharacterised lincRNA), socs3a, nfkbiaa, tnfrsf9a, zgc:153932 (gp2-like), sult5a1, si:dkey-239b22.1 (tecta-like), si:dkey-247k7.2,
cr855311.1 (uncharacterised non-coding RNA), cp, cbx7a, c3a.6. Gene names in brackets are inferred by manual annotations based on protein
alignments performed on the UniProt database (https://www.uniprot.org/). For genes not predicted to encode a protein, manual annotations were
inferred from the Ensembl database (https://www.ensembl.org/). See also S1 and S2 Tables for the extended gene lists and S2 Fig for in-depth
exploration of the data.
https://doi.org/10.1371/journal.ppat.1008006.g002
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S. sonnei O-Ag can directly lead to zebrafish death (i.e. due to increased toxicity of the bacterial
lipopolysaccharide conjugated with O-Ag), we injected live or heat-killed WT or ΔO-Ag S. son-
nei. In this case, only live WT S. sonnei induced zebrafish death, indicating that S. sonnei O-Ag
is not toxic per se (S3M Fig).
S. sonnei O-antigen can counteract clearance by zebrafish neutrophils
Considering that injection of S. sonnei induces recruitment of both macrophages and neutro-
phils to the HBV at 6 hpi (Fig 4A and 4B), we tested the role of these immune cells in S. sonnei
virulence. We used the zebrafish line Tg(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:nfsB.mCherry)c264 in
which treatment with the pro-drug Metronidazole (Mtz) results in macrophage ablation
(S4A–S4C Fig). Here, the presence or absence of macrophages does not significantly affect
zebrafish survival or bacterial burden (Fig 4C and 4D, S4D and S4E Fig). In contrast, when
both macrophages and neutrophils are depleted using pu.1 morpholino oligonucleotide, we
observe a significant increase in zebrafish susceptibility to S. sonnei (Fig 4E and 4F, S4F–S4H
Fig).
Considering an important role for neutrophils in Shigella control [22,24], and the signifi-
cant upregulation of genes involved in granulopoiesis/neutrophil chemotaxis identified by
dual-RNAseq profiling (e.g., cebpb, atf3, cxcl8a, cxcl18b (Fig 1C and 1D, Fig 2E), we reasoned
Fig 3. S. sonnei virulence depends on its O-antigen. A,B. Virulence of S. sonnei depends on its virulence plasmid. Survival curves (A) and Log10-
transformed CFU counts (B) of larvae injected in the HBV with S. sonnei -pSS (grey), Δmxid (blue) or WT (red) strains. Experiments are cumulative of 3
biological replicates. In B, full symbols represent live larvae and empty symbols represent larvae that at the plating timepoint had died within the last 16
hours. Statistics: Log-rank (Mantel-Cox) test (A); one-way ANOVA with Sidak’s correction on Log10-transformed data (B); ns, non-significant;
��p<0.0021; ����p<0.0001. See also S3H–S3K Fig for experiments at 32.5˚C. C,D. Virulence of S. sonnei depends on its O-antigen. Survival curves (C)
and Log10-transformed CFU counts (D) of larvae injected in the HBV with S. sonnei ΔO-Ag (blue) or WT (red) strains. Experiments are cumulative of 3
biological replicates. In D, full symbols represent live larvae and empty symbols represent larvae that at the plating timepoint had died within the last 16
hours. Statistics: Log-rank (Mantel-Cox) test (C); unpaired t-test on Log10-transformed data (D);
����p<0.0001. See also S3H–S3K Fig for experiments at
32.5˚C.
https://doi.org/10.1371/journal.ppat.1008006.g003
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Fig 4. S. sonnei O-antigen can counteract clearance by zebrafish neutrophils. A,B. Macrophages and neutrophils are recruited to S. sonnei in vivo. Larvae of the Tg
(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:nfsB.mCherry)c264 strain (labelling macrophages, A) or of the Tg(lyz:dsRed)nz50 strain (labelling neutrophils, B) were injected with PBS
(blue) or S. sonnei (red) in the HBV. Recruitment was quantified from images at 6 hpi. Experiments are cumulative of 3 biological replicates. Statistics: two-tailed Mann-
Whitney test; ����p<0.0001. C,D. Macrophage ablation does not increase susceptibility to S. sonnei. Survival curves (C) and Log10-transformed CFU counts (D) of Tg
(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:nfsB.mCherry)c264 larvae which were treated with either Metronidazole (Mtz, macrophage ablated group, blue) or control DMSO
vehicle (DMSO, red) prior to infection in the HBV with S. sonnei. Experiments are cumulative of 3 biological replicates. In D, full symbols represent live larvae and
empty symbols represent larvae that at the plating timepoint had died within the last 16 hours. Statistics: Log-rank (Mantel-Cox) test (C); unpaired t-test on Log10-
transformed data (D); ns, non-significant. E,F. pu.1 morpholino knockdown increases susceptibility to S. sonnei. Survival curves (E) and Log10-transformed CFU
S. sonnei O-antigen and dysentery incidence
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that ΔO-Ag S. sonnei may be attenuated in vivo because of its inability to counteract neutrophil
clearance. Consistent with this hypothesis, infection of pu.1 morphants at 30 hpf (when deple-
tion of immune cells is complete) with ΔO-Ag S. sonnei led to significantly increased zebrafish
death, compared to control morphants at the same developmental stage (Fig 4G and 4H, S4I
and S4J Fig).
S. sonnei can resist phagolysosome acidification and promote neutrophil
cell death in an O-antigen-dependent manner
Using high resolution confocal microscopy, we observed that S. sonnei mostly reside within
neutrophil phagosomes at 3 hpi (Fig 5A). Additionally, staining of live bacteria with a pH sen-
sitive dye (pHrodo) showed that intracellular S. sonnei mostly reside within acidic compart-
ments at 4 hpi (Fig 5B). We therefore hypothesised that O-Ag may promote bacterial survival
during phagolysosome acidification. To test this, we measured the growth of WT or ΔO-Ag S.
sonnei grown in liquid culture at different pH. While the growth of both strains is similar at
neutral pH = 7, WT S. sonnei grew significantly faster than ΔO-Ag S. sonnei at pH = 5 (Fig 5C
and 5D, S5A and S5B Fig). Consistent with a role for O-Ag in tolerance to phagolysosome
acidification, transmission electron microscopy (TEM) of zebrafish larvae at 3 hpi showed
intact and dividing WT S. sonnei cells, versus disrupted and non-dividing ΔO-Ag S. sonnei
cells, in neutrophil phagosomes (Fig 5E and 5F, S5C Fig). Moreover, only in the case of WT S.
sonnei could we observe compromised nuclei and extranuclear chromatin in zebrafish cells
harbouring infection, indicative of necrotic cell death (S5D Fig).
To investigate whether neutrophil cell death mediated by S. sonnei is dependent on O-Ag,
we quantified neutrophils at the whole animal level in WT or ΔO-Ag S. sonnei infected larvae at
6 and 24 hpi. Infection with WT S. sonnei resulted in significantly more neutrophil cell death
than infection with ΔO-Ag S. sonnei (Fig 5G–5J). In the case of S. flexneri infection, neutrophils
are recognised to die via necrosis [29]. Since no pharmacological reagent exists to directly test
necrosis in vivo, we sought to rule out other cell death pathways in S. sonnei infected larvae and
inhibited apoptosis, pyroptosis and/or necroptosis using the pan-caspase inhibitor Q-VD-OPh
(an inhibitor of apoptosis and pyroptosis), Necrostatin-1 and/or Necrostatin-5 (inhibitors of
necroptosis) (S5E Fig). All inhibitors tested fail to significantly increase zebrafish survival. Con-
sidering this, and that infected zebrafish cells appeared necrotic by TEM (S5D Fig), we conclude
that neutrophils infected with S. sonnei undergo necrosis (and not a programmed mechanism
of cell death) because of bacterial survival enabled by S. sonnei O-Ag.
Phagolysosome acidification controls S. sonnei clearance by zebrafish and
human neutrophils
To test the role of phagolysosome acidification during S. sonnei infection in vivo, we treated
infected larvae with Bafilomycin, an inhibitor of vacuolar H+ ATPase (V-ATPase). Consistent
with a role for phagolysosome acidification in S. sonnei control, Bafilomycin treatment signifi-
cantly increased zebrafish susceptibility to S. sonnei (Fig 6A). Bafilomycin treatment also
counts (F) of pu.1 morphant (blue) or control (red) larvae infected in the HBV with S. sonnei. Experiments are cumulative of 3 biological replicates. In F, full symbols
represent live larvae and empty symbols represent larvae that at the plating timepoint had died within the last 16 hours. Statistics: Log-rank (Mantel-Cox) test (E);
unpaired t-test on Log10-transformed data (F); ns, non-significant;
����p<0.0001. G,H. Virulence of ΔO-Ag S. sonnei can be observed in pu.1 morphants. Survival
curves (G) and Log10-transformed CFU counts (H) of pu.1 morphant (blue) or control (red) larvae infected in the HBV with ΔO-Ag S. sonnei. To allow full ablation of
immune cells by morpholino knockdown, infections were performed at 30 hours post-fertilisation (hpf). Experiments are cumulative of 3 biological replicates. In H, full
symbols represent live larvae and empty symbols represent larvae that at the plating timepoint had died within the last 16 hours. Statistics: Log-rank (Mantel-Cox) test;
����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008006.g004
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increased zebrafish susceptibility to ΔO-Ag S. sonnei (Fig 6B), highlighting the virulence of
ΔO-Ag S. sonnei in the absence of phagolysosome acidification.
Considering that inhibition of phagolysosome acidification increases zebrafish susceptibil-
ity to S. sonnei, we hypothesised that promotion of acidification may overcome tolerance pro-
vided by O-Ag in vivo. V-ATPases mediate phagolysosome acidification by using ATP to
pump protons in acidifying compartments. Injections of 200 μM ATP 3 h prior to S. sonnei
infection significantly increases zebrafish survival (Fig 6C). Bafilomycin directly antagonises
V-ATPase activity. In agreement with this, treatment of S. sonnei infected larvae with Bafilo-
mycin counteracts the beneficial effects of ATP injection for host defence (Fig 6D).
To test the role of S. sonnei O-Ag in human infection, we isolated peripheral neutrophils
from healthy donors and infected them with WT or ΔO-Ag S. sonnei (Fig 6E). In agreement
with results from zebrafish infection, ΔO-Ag S. sonnei are significantly more susceptible to
human neutrophil-mediated clearance than WT bacteria, and Bafilomycin treatment increased
susceptibility of human neutrophils to ΔO-Ag S. sonnei (Fig 6F). Plasmid reintroduction of the
O-Ag biosynthesis system in ΔO-Ag S. sonnei (ΔO-Ag+pSSO-Ag) could restore the resistance of
mutant bacteria to neutrophil killing to levels observed using WT bacteria (Fig 6E and 6F;
S3G Fig). Collectively, these results show that S. sonnei O-Ag enables neutrophil tolerance in
zebrafish and human neutrophils, and suggest that promotion of phagolysosome acidification
is a novel approach to counteract S. sonnei infection (Fig 6G and 6H).
The innate immune system can be trained to control S. sonnei in vivo
Neutrophils of zebrafish larvae can be trained to protect against S. flexneri infection [25]. To
test if we can enhance innate immunity to S. sonnei, we developed a S. sonnei reinfection assay
(Fig 7A). For this, larvae at 2 dpf were injected in the HBV with PBS or a sublethal dose (~80
CFU) of WT or ΔO-Ag GFP-S. sonnei. At 48 hpi, we screened larvae and found that ~20% of
WT S. sonnei infected larvae are unable to clear infection (S6A and S6B Fig); these larvae were
therefore excluded from further analysis. Next, PBS-injected larvae or larvae clearing the pri-
mary infection (as determined by fluorescence microscopy) were infected with a lethal dose
(~8000 CFU) of mCherry-S. sonnei. Strikingly, injection of larvae with WT S. sonnei (but not
ΔO-Ag S. sonnei) significantly increased survival, as compared to PBS-injected larvae (Fig 7B
and 7C). These experiments show that larvae exposed to a sublethal dose of S. sonnei are pro-
tected against a secondary lethal dose of S. sonnei in an O-Ag-dependent manner, and may
have important implications in vaccine design.
Discussion
Why S. sonnei is emerging globally as a primary agent of bacillary dysentery has been
unknown. Here, we discover that S. sonnei is more virulent than S. flexneri in vivo because of
Fig 5. S. sonnei can resist phagolysosome acidification and promote neutrophil cell death in an O-antigen-dependent manner. A. S. sonnei is collected by
neutrophils in large phagosomes. Larvae of the Tg(lyz:dsRed)nz50 strain (labelling neutrophils) were injected in the HBV with WT GFP-S. sonnei. Image taken
at 3 hpi. Scale bar = 20 μm. B. S. sonnei is acidified in immune cell phagosomes. Larvae were injected in the HBV with WT GFP-S. sonnei which was also
stained with pHrodo, a pH-sensitive dye that turns red in acidic environments. Image taken at 4 hpi, where GFP signal is attenuated for bacteria residing in
acidified phagosomes (i.e. GFP is unstable and quenched at pH<6). Dashed lines highlight the outline of individual phagocytes. Scale bar = 10 μm. C,D. S.
sonnei O-antigen contributes to acid tolerance in vitro. Growth curves of ΔO-Ag (blue) or WT (red) S. sonnei, cultured in tryptic soy broth adjusted to pH = 5
(C) or 7 (D). Statistics: unpaired t-test at the latest timepoint; ns, non-significant; ��p<0.0021. E,F. S. sonnei requires the O-antigen to survive in phagosomes.
Transmission electron micrographs of infected phagocytes from zebrafish larvae at 3 hpi with WT (E) or with ΔO-Ag (F) S. sonnei. E shows an intact phagocyte
and S. sonnei residing within a phagosome (arrow points at phagosomal membrane). F shows that ΔO-Ag S. sonnei bacteria being degraded by a phagocyte
(arrows point at region of major loss of bacterial cell integrity). Scale bars = 3 μm (E); 2 μm (F). G-J. The O-antigen is required for S. sonnei-mediated killing
of neutrophils. Representative micrographs of larvae of the Tg(lyz:dsRed)nz50 strain injected in the HBV with PBS (G), GFP-ΔO-Ag (H) or WT (I) S. sonnei at 6
hpi and quantification of total neutrophil number at 6 and 24 hpi (J). Statistics: Kruskal-Wallis test with Dunn’s correction; ns, non-significant; ����p<0.0001.
Scale bars = 250 μm.
https://doi.org/10.1371/journal.ppat.1008006.g005
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Fig 6. Phagolysosome acidification controls S. sonnei clearance by zebrafish and human neutrophils. A,B. Bafilomycin treatment increases susceptibility
to WT and ΔO-Ag S. sonnei. Survival curves of larvae treated with control DMSO vehicle (blue) or Bafilomycin (red) upon infection in the HBV with WT (A)
or ΔO-Ag (B) S. sonnei. Experiments are cumulative of 3 biological replicates. Bacterial input: ~7000 CFU. Statistics: Log-rank (Mantel-Cox) test; ����p<0.0001.
C. ATP injections protect against S. sonnei infection. Survival curves of larvae injected in the HBV with control water (blue) or ATP (red) 3 hours prior to
infection of the same compartment with S. sonnei. Experiments are cumulative of 3 biological replicates. Bacterial input: ~7000 CFU. Statistics: Log-rank
(Mantel-Cox) test; ����p<0.0001. D. Bafilomycin treatment and ATP injections counteract each other. Survival curves of larvae injected in the HBV with
ATP 3 hours prior to infection of the same compartment with S. sonnei and treatment with control DMSO vehicle (blue) or Bafilomycin (red). Experiments are
cumulative of 3 biological replicates. Bacterial input: ~7000 CFU. Statistics: Log-rank (Mantel-Cox) test; ����p<0.0001. E,F. S. sonnei O-Ag is required to
counteract acidification-mediated clearance by human neutrophils. ΔO-Ag (grey), complemented strain (ΔO-Ag+pSSO-Ag, blue) or WT (red) S. sonnei were
incubated with peripheral human neutrophils and exposed to DMSO (vehicle control treatment, E) or Bafilomycin (F). Difference in bacterial killing was
quantified by plating from lysates of infected neutrophils at 1 hpi. Experiments are cumulative of 3 biological replicates from 3 independent donors. Statistics:
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neutrophil tolerance mediated by its O-Ag. We also show that increased phagolysosomal acidi-
fication or innate immune training can promote S. sonnei clearance by neutrophils in vivo and
propose new approaches to S. sonnei control.
The O-Ag, a lipopolysaccharide component of Gram-negative bacteria consisting of
repetitive surface oligosaccharide units, is a major target for the immune system and bacterio-
phages. As a result, it is viewed that co-evolution of bacteria with their hosts or phages has led
to significant variation in O-Ag structure/composition across bacterial strains [30]. In the case
of most Shigella spp., significant variation of their E. coli-like O-Ag is observed across strains
[28]. Interestingly, genes involved in S. sonnei O-Ag biosynthesis are non-homologous to
those of other Shigella spp., highly conserved across S. sonnei strains and the only example of a
virulence-plasmid encoded O-Ag system (in other Shigella spp. the O-Ag is encoded by
one-way ANOVA with Sidak’s correction; ns, non-significant; �p<0.0332; ��p<0.0021. G,H. Model of S. sonnei O-antigen counteracting neutrophils in vivo.
Upon phagocytosis of WT S. sonnei (green), zebrafish neutrophils (red) rapidly acidify phagolysosomes containing bacteria. However, S. sonnei can tolerate this
environment because of its O-antigen. S. sonnei replication leads to neutrophil and host death (G). S. sonnei without O-antigen fails to counteract acidification
of neutrophil phagolysosomes. In this case, neutrophils clear infection and the host survives (H).
https://doi.org/10.1371/journal.ppat.1008006.g006
Fig 7. Innate immunity can be trained to control S. sonnei in vivo. A. Model for S. sonnei reinfection. 2 dpf embryos were primed with PBS or a sublethal dose of S.
sonnei. At 48 hours post primary infection (hp1i), larvae where challenged with a lethal dose of S. sonnei and monitored by survival assay for 72 hours post-secondary
infection (hp2i). B,C. Innate immune training to S. sonnei is dependent on O-antigen. Survival curves (B) and Log10-transformed CFU counts (C) of 4 dpf larvae
infected in the HBV with lethal dose (~8000 CFU) of mCherry-WT S. sonnei. 48 hours prior to infection with lethal dose, embryos were primed by delivering PBS
(grey), or a sublethal dose (~80 CFU) of GFP-ΔO-Ag (blue) or GFP-WT (red) S. sonnei. Experiments are cumulative of 4 (B) or 3 (C) biological replicates. In C, full
symbols represent live larvae and empty symbols represent larvae that at the plating timepoint had died within the last 16 hours. Statistics: Log-rank (Mantel-Cox) test
(B); one-way ANOVA with Sidak’s correction on Log10-transformed data (C); ns, non-significant;
�p<0.0332; ���p<0.0002; ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1008006.g007
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chromosomal genes) [28]. Consistent with this, acquisition of O-Ag genes from P. shigelloides
is considered a defining event for the emergence of S. sonnei [16,31]. We show that S. sonnei
O-Ag enables bacteria to resist phagolysosome acidification and promotes neutrophil cell
death. In agreement with this, chemical inhibition or promotion of phagolysosome acidifica-
tion respectively decreases and increases neutrophil control of S. sonnei and zebrafish survival.
In future studies it will be important to investigate the precise role of S. sonnei O-Ag in toler-
ance to phagolysosome acidification in neutrophils, and inspire new approaches for S. sonnei
control.
Innate immune memory is a primitive form of immune memory conserved across verte-
brates [32,33]. We reveal that larvae injected with a sublethal dose of S. sonnei are protected
against a secondary lethal dose of S. sonnei in an O-Ag-dependent manner. Although there is
no vaccine currently available for S. sonnei, our results suggest that training innate immune
memory against O-Ag should be considered for vaccine development. Moreover, it is tempting
to speculate that innate immune memory may help to explain the increasing S. sonnei burden
in regions where improved water sanitisation has eliminated P. shigelloides and subsequently
reduced cross-immunisation against S. sonnei O-Ag [16,17]. Consistent with this, the inci-
dence of S. sonnei infection is mostly observed in very young children (<5 years old) [34–38],
an age group where trained innate immunity has been shown to play an important protective
role [32,33,39–41].
Collectively, these findings reveal O-antigen as an important therapeutic target against
bacillary dysentery. These findings also have major implications for our evolutionary under-
standing of Shigella and may explain the increasing burden of S. sonnei in developing
countries.
Materials and methods
Ethics statements
Animal experiments were performed according to the Animals (Scientific Procedures) Act
1986 and approved by the Home Office (Project licenses: PPL P84A89400 and P4E664E3C).
All experiments were conducted up to 7 days post fertilisation.
Tissue samples from anonymised human donors (neutrophils) were provided by the Impe-
rial College Healthcare NHS Trust Tissue Bank 12275. Other investigators may have received
samples from these same tissues.
Zebrafish
Zebrafish lines used here were the wildtype (WT) AB strain, macrophage reporter line Tg
(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:nfsB.mCherry)c264 and neutrophil reporter line Tg(lyz:
dsRed)nz50. Unless specified otherwise, eggs, embryos and larvae were reared at 28.5˚C in Petri
dishes containing embryo medium, consisting of 0.5x E2 water supplemented with 0.3 μg/ml
methylene blue (Sigma-Aldrich, St. Louis, Missouri). For injections and in vivo imaging,
anaesthesia was obtained with buffered 200 μg/ml tricaine (Sigma-Aldrich) in embryo
medium. Protocols are in compliance with standard procedures as reported at zfin.org.
Bacterial preparation and infection delivery
Unless specified otherwise, GFP fluorescent or non-fluorescent S. flexneri M90T or S. sonnei
53G were used. Mutant, transgenic and WT strains are as indicated in the Figure legends and
further detailed in S3 Table.
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Bacteria were grown on trypticase soy agar (TSA, Sigma-Aldrich) plates containing 0.01%
Congo red (Sigma-Aldrich) supplemented, when appropriate, with antibiotics (Carbenicillin
100 μg/ml (Sigma-Aldrich), Kanamycin 50 μg/ml (Sigma-Aldrich), Streptomycin 50 μg/ml
(Sigma-Aldrich)). Individual colonies were selected and grown O/N, 37˚C/200 rpm, in 5 ml
trypticase soy broth (TSB, Sigma-Aldrich) supplemented with the appropriate antibiotics as
above. For injections, bacteria were grown to Log phase by diluting 400 μl of O/N culture in 20
ml of fresh TSB (supplemented, where appropriate, with 25 μg/ml Carbenicillin) and culturing
as above until an optical density (OD) of 0.55–0.65 at 600 nm.
Bacteria were spun down, washed in phosphate buffer saline (PBS, Sigma-Aldrich) and
resuspended at the desired concentration in a final injection buffer containing 2% polyvinyl-
pyrrolidone (Sigma-Aldrich) and 0.5% phenol red (Sigma-Aldrich) in PBS (injection buffer
alone is referred into the text as PBS group). Heat-killed bacteria were prepared as described
above, but the bacterial inoculum was incubated for 30 min at 60˚C prior to injection.
Unless specified otherwise, 1–2 nl of bacterial suspension (bacterial load as indicated in the
individual experiments) or control solution were microinjected in the hindbrain ventricle
(HBV) of 3 days post-fertilisation (dpf) zebrafish larvae (or at 2 dpf followed by reinfection at 4
dpf for reinfection assays, Fig 7B and 7C). In S1G and S1H Fig infection was delivered intra-
venously (IV), via the Duct of Cuvier.
Bacterial enumeration was performed a posteriori by mechanical disruption of infected lar-
vae in 0.4% Triton X-100 (Sigma-Aldrich) and plating of serial dilutions onto Congo red-TSA
plates.
The S. sonnei 53G Δtssb strain was created using the λ Red recombinase approach [42].
Briefly, the aphA-3 cassette encoding Kanamycin resistance with flanking extensions homolo-
gous to the upstream and downstream regions of tssB was created by overlapping PCR using
primers #1 and #2 (upstream tssB), #3 and #4 (downstream tssB) and #5 and #6 (KanR). Primer
sequences are reported in S4 Table. The linear fragment was amplified (primers #1 and #4),
parental plasmid removed by DpnI digestion and the linear fragment gel purified. The linear
fragment was transformed into electrocompetent S. sonnei 53G containing pKD46; the λ Red
recombinase genes on this plasmid were induced by arabinose prior to transformation. Δtssb
colonies were selected on Kanamycin plates, and gene disruption was verified by multiple
PCRs (primers #7 and #8, #6 and #8). pKD46 loss was confirmed by Ampicillin sensitivity.
Successful gene disruption was also confirmed by sequencing of the entire region using prim-
ers #7 and #8.
The S. sonnei 53G ΔO-Ag and its complemented strain ΔO-Ag+pSSO-Ag are described in [43].
Briefly, the O-Ag synthesis operon wbgT-wbgZ was replaced by a Kanamycin cassette using
the λ Red recombinase approach as described above. This mutant was complemented in trans
with the entire O-Ag synthesis operon (including the upstream chain length regulator wzz and
102 bp 5’ of wzz and 76 bp 3’ of wbgZ to include endogenous transcriptional promoters and
terminators) inserted into a low copy number vector pSEVA421:SmR. To validate strains,
crude LPS was isolated from ~5 ml O/N cultures (~16 h) equalised by optical density. The LPS
preparation was run on a 12% SDS-PAGE gel and blotted using an anti-S. sonnei Phase I anti-
body (ab78678, Abcam, Cambridge, UK).
To quantify the loss of virulence plasmid (S3E Fig) GFP-labelled bacteria were injected in
zebrafish larvae (1 nl, ~7000 CFU/nl) as above or spotted onto Congo red-TSA plates (10 μl,
~7000 CFU/nl). Larvae and plates were incubated at 28.5˚C for 24 h, bacteria were harvested
from plates or larvae, and plated in serial dilutions on Carbenicillin-supplemented plates,
grown O/N at 37˚C and quantified for loss of virulence plasmid (white versus red colonies) as
described elsewhere [27].
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To address sensitivity of bacterial strains to acidic pH (Fig 5C and 5D, S5A and S5B Fig),
bacteria were first grown O/N as described above, diluted to the same initial OD600 (0.10) in
pH-adjusted TSB and bacterial growth was monitored by OD600 measurements at different
timepoints. The pH of TSB was adjusted by addition of few drops of concentrated HCl
(Sigma-Aldrich).
Infection of human neutrophils
At least 5 ml of peripheral blood was drawn from healthy volunteers, using EDTA as an antico-
agulant (BD Vacutainer, Becton Dickinson, Franklin Lakes, New Jersey). Neutrophils were iso-
lated by gradient centrifugation using PolymorphprepTM (Axis-Shield, Dundee, UK),
according to the manufacturer’s guidelines and previously described protocols [44]. Residual
erythrocytes were removed by incubation for 10 minutes at 37˚C in erythrocyte lysis buffer,
consisting of 0.83% w/v NH4Cl (Sigma-Aldrich), 10 mM NaOH-buffered HEPES (4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid, Sigma-Aldrich), pH 7.4. Purified neutrophils were
washed in Hank’s Balanced Salt Solution (HBSS) without Calcium and Magnesium (HBSS
-Ca2+/-Mg2+, Thermo Fisher Scientific, Waltham, Massachusetts), resuspended in neutrophil
medium, consisting of HBSS with Calcium and Magnesium (HBSS +Ca2+/+Mg2+, Thermo
Fisher Scientific) and 0.1% porcine gelatin (Sigma-Aldrich), counted using trypan blue stain-
ing, and ultimately diluted at a density of 2 x 106 live cells/ml in neutrophil medium [44]. Prior
receiving infection, 105 neutrophils (50 μl of neutrophil resuspension) were pre-incubated
with Bafilomycin (111,11 nM, Sigma-Aldrich) [45,46] or DMSO at vehicle control levels for 30
minutes with gentle shaking at 37˚C in 48-well plates and in a total volume of 180 μl of neutro-
phil medium.
For neutrophil infections, Shigella was cultured as described above, but ultimately resus-
pended in neutrophil medium at a density of 5 x 104 CFU/ml and 103 bacteria (20 μl of bacte-
rial resuspension) were added to the neutrophil resuspension and incubated for 1 h with
gentle shaking at 37˚C. Neutrophils were lysed by incubation on ice and addition of 7.5 μl of
0.4% Triton X-100 (Sigma-Aldrich) per well. Total CFUs were calculated by plating 20 μl of
the lysate, comparing infected neutrophil samples to control samples, lacking neutrophils [44].
pHrodo staining
pHrodo Red, succinimidyl ester (Thermo Fisher Scientific) was prepared according to the
manufacturer’s guidelines. 0.25 μl of stock solution were used to stain 200 μl of a ~7000 CFU/
nl bacterial suspension in PBS. Bacteria were incubated in the dark at 28.5˚C for 30 minutes,
washed 3 times in PBS, resuspended in 2% polyvinylpyrrolidone and 0.5% phenol red in PBS
and injected in the HBV as above.
Light and electron microscopy imaging
Stereo fluorescent microscopy images where acquired using Leica M205FA stereo fluorescent
microscopes (Leica, Wetzlar, Germany). Zebrafish larvae were anaesthetised and aligned on
1% agarose plates in embryo medium.
For high-resolution confocal microscopy, imaging was performed using a Zeiss LSM 880
(Carl Zeiss, Oberkochen, Germany). Larvae were positioned in 35-mm-diameter glass-bottom
MatTek dishes and imaged with 20× air or 40× water immersion objectives. Image files were
processed using ImageJ/FIJI software.
For electron microscopy analysis, infected zebrafish larvae and controls were fixed at 3 hpi
in 0.5% glutaraldehyde/200 nM sodium cacodylate buffer for 2 h and washed in cacodylate
buffer only. Samples where then fixed in reduced 1% osmium tetroxide/1.5% potassium
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ferricyanide for 60 min, washed in distilled water and stained overnight at 4˚C in 0.5% magne-
sium uranyl acetate. Specimens were then washed in distilled water, dehydrated in graded eth-
anol, infiltrated with propylene oxide and then graded Epon/PO mixtures until final
embedding in full Epon resin in coffin moulds. Resin was allowed to polymerise at 56˚C over-
night, then semi-thin survey sections were cut and stained. Final ultrathin sections (typically
50–70 nm) and serial sections were collected on Formvar coated slot grids, stained with Rey-
nold’s lead citrate and examined in a FEI Tecnai electron microscope with CCD camera image
acquisition system.
qRT-PCR
qRT-PCRs were performed using StepOne Plus machine (Applied Biosystems, Foster City,
California) and a SYBR green master mix (Applied Biosystems). Briefly, RNA was isolated
from pools of whole larvae using RNeasy mini kit (Qiagen, Hilden, Germany). cDNA was
obtained using a QuantiTect reverse transcription kit (Qiagen). Samples were run in technical
duplicates and quantification was obtained using the 2−ΔΔCT method and eef1a1a as a house-
keeping gene. S4 Table reports all primers used in this study.
Enumeration of immune cells
For recruitment assays, immune cells attracted to the infection site were enumerated from
images by counting Tg(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:nfsB.mCherry)c264 (for macrophages)
or Tg(lyz:dsRed)nz50 (for neutrophils) positive cells in the hindbrain/midbrain. To quantify
neutrophil death, the same neutrophil line was used to count immune cells at the whole animal
level.
Chemical treatments, ablations and knockdowns in zebrafish
Macrophages were ablated by exposing hatched 2 dpf Tg(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:
nfsB.mCherry)c264 embryos to Metronidazole (Mtz, Sigma-Aldrich) at 100 μM concentration
in 1% DMSO (Sigma-Aldrich) for 24 h [47]. Treatment with 1% DMSO alone was used as a
control.
Morpholinos were purchased from Gene Tools (Philomath, Oregon). Injections of pu.1
(spi1ab) morpholino (2 nl, 0.5 mM in 0.5% phenol red) were performed at 1-cell stage and the
same volume and concentration of a standard control morpholino was used as negative con-
trol. Morpholino sequences are reported in S4 Table.
Necrostatin-1 (10 μM, Santa Cruz Biotechnology, Dallas, Texas), Necrostatin-5 (10 μM,
Santa Cruz) [48], Q-VD-OPh (50 μM, Sigma-Aldrich) [49] and Bafilomycin (200 nM, Sigma-
Aldrich) [45,50] were provided by bath exposure from 0 hpi for the whole infection course.
Exposure to DMSO at vehicle concentration (0.67% for Necrostatin-1, Necrostatin-5,
Q-VD-OPh, and 0.2% for Bafilomycin) was used as a control. Priming with ATP injections
was performed by injecting 1 nl of 200 mM ATP in the hindbrain 3 h prior infection. Injection
of 1 nl of sterile water was used as a vehicle control.
Dual-RNAseq sample preparation and analysis
RNA samples for dual-RNAseq were extracted in triplicate from infected larvae at 24 hpi using
24 larvae/sample. As a control for the host transcriptome, RNA was isolated from correspond-
ing PBS injected larvae at the same timepoint. As a control for S. sonnei transcriptome, RNA
was isolated from the same culture used for injection, but diluted 50x and subcultured at
28.5˚C until it reached the OD of ~0.6 in a total volume of 5 ml. Samples were snap frozen at
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-80˚C, then 100 μl of RNA protect bacteria reagent (Qiagen) was added, followed by mechani-
cal trituration with a pestle blender. Samples were supplemented with 100 μl of 30 mM Tris-
HCl/1 mM EDTA solution at pH = 8, 33 μl of 50 mg/ml lysozyme (Thermo Fisher Scientific),
33 μl of proteinase K >600 U/ml (Thermo Fisher Scientific) and shaken for 20 min RT. Lysis
was completed by adding 700 μl of RTL buffer (Qiagen), 3 μl of 1 M dithiothreitol (Sigma-
Aldrich) and mechanical disruption. Undigested debris were spun down 3 min 10000 rpm and
the supernatant was supplemented with 500 μl of 100% ethanol prior loading onto RNeasy
mini columns (Qiagen). From this step onwards, the manufacturer’s guidelines were followed
for RNA purification. RNA quality and integrity were assessed by using NanoDrop and Non-
denaturing agarose gel electrophoresis. For further quality check, RNA sequencing, library
construction and reads count, samples were outsourced to Vertis Biotechnologie AG (Freising,
Germany). Bacterial and host mRNA were enriched prior library preparation by using Ribo-
Zero Gold rRNA Removal Kit (Epidemiology, Illumina, San Diego, California). The zebrafish
genome assembly GRCz11 (http://www.ensembl.org/Danio_rerio) and the S. sonnei 53G
genome assembly ASM28371v1 (https://www.ncbi.nlm.nih.gov/assembly/406998) were used
to guide mapping of host and pathogen reads, respectively. The average library depths for the
different sample groups were: 8658688 +/- 598491 reads (PBS injected larvae), 7771779 +/-
804881 reads (infected larvae), 11315345 +/- 551602 reads (S. sonnei in vitro) and 702385 +/-
12785 reads (S. sonnei in vivo).
RNAseq statistical analysis was performed using DESeq2 package in R [51,52]. Genes that
were not represented with at least 6 reads cumulative from all samples were excluded from the
analysis a priori. Genes were accepted as differentially expressed if the DESeq2 Log2(Fold
Change) > |1| and DESeq2 adjusted p value (padj) < 0.05. Heatmaps (Fig 2D and 2E) were
obtained from counts per million (CPM) reads using the “pheatmap” package (https://CRAN.
R-project.org/package=pheatmap). Principal component analysis (PCA) (S2A and S2B Fig)
was also performed in R from CPM reads, using the dedicated PCA tools [52]. All the other
graphs were generated using GraphPad Prism 7 (GraphPad Software, San Diego, California).
Host pathway enrichment analysis and enrichment of transcription factor binding sites were
performed using ShinyGO v0.60 (http://bioinformatics.sdstate.edu/go/) [53]. Due to poor
annotation of S. sonnei Gene Ontology functions, we employed eggNOG-mapper v2 to anno-
tate functions using orthologous assignments [54]. In total, 3918 S. sonnei protein sequences
were retrieved from uniprot.org and scanned for orthologues. 2777 genes were assigned at
least to one GO term. Out of the 1538 S. sonnei genes that were significantly differentially
expressed, 860 were assigned to a least one GO term. Pathway enrichment analysis was per-
formed for significantly differentially expressed genes in R, using the ‘fgsea’ Bioconductor
package [55].
Statistical analysis and data processing
Except for graphs performed in R, all other graphs and statistical analyses were performed
using GraphPad Prism 7. Statistical difference for survival curves were analysed using a Log-
rank (Mantel-Cox) test. Differences in CFU recovery and gene expression levels were quanti-
fied on Log10-transformed or Log2-transformed data, respectively. To avoid Log(0), i.e., when
no colonies were recovered, the CFU counts were assigned as 1. When only 2 groups were
compared, significant differences were tested using an unpaired t-test at each timepoint.
When more than 2 groups were compared, a one-way ANOVA with Sidak’s correction was
used. Unpaired t-test (comparison between 2 groups) or one-way ANOVA with Sidak’s cor-
rection (comparison between more than 2 groups) was also applied to S3E Fig, Fig 5C and
5D, S5A and S5B Fig and Fig 6E and 6F but on non-transformed data, as in this case a
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parametric distribution could be assumed. Statistics for categorical data were obtained by a
two-sided chi-squared contingency test (S1D Fig, S6A Fig). For statistical quantification of
immune cell numbers (non-parametric data), a two-tailed Mann-Whitney test (comparison
between 2 groups) or a Kruskal-Wallis test with Dunn’s correction (comparison between more
than 2 groups) was used.
Supporting information
S1 Fig. (Related to Fig 1) S. sonnei is more virulent than S. flexneri in a zebrafish infection
model. A,B. Dose response to S. sonnei infection. Survival curves (A) and Log10-transformed
CFU counts (B) of larvae injected in the HBV with increasing doses of S. sonnei. ~200 CFU
range: 100–300 CFU (grey); ~600 CFU range: 400–700 CFU (blue); ~1500 CFU range: 1000–
2000 CFU (green); ~5000 CFU: 4000–6000 CFU (red). Experiments are cumulative of 3 bio-
logical replicates. In B, full symbols represent live larvae and empty symbols represent larvae
that at the plating timepoint had died within the last 16 hours. Statistics: Log-rank (Mantel-
Cox) test (A); one-way ANOVA with Sidak’s correction on Log10-transformed data (B); ns,
non-significant; ��p<0.0021; ����p<0.0001.
C-F. S. sonnei can disseminate from the injection site. Representative images of three larvae
injected in the HBV with ~20000 CFU of GFP-labelled S. flexneri (C, compare to Fig 1E and
1F). The frequency of larvae with bacterial dissemination out of the HBV at 24 hpi is signifi-
cantly higher for the S. sonnei-infected group when compared to the S. flexneri infected group
(even when S. flexneri input is ~3-fold higher than S. sonnei input) (D). Survival curves (E) and
Log10-transformed CFU counts (F) of larvae injected in the HBV with ~7000 CFU S. flexneri
(grey), ~20000 CFU of S. flexneri (blue) or ~7000 CFU S. sonnei (red). Experiments are cumu-
lative of 3 biological replicates. In E, full symbols represent live larvae and empty symbols rep-
resent larvae that at the plating timepoint had died within the last 16 hours. Due to poor larval
survival at 72 hpi, CFU data are available for< 3 larvae per biological replicate. Statistics: two-
sided chi-squared contingency test (D); Log-rank (Mantel-Cox) test (E); one-way ANOVA
with Sidak’s correction on Log10-transformed data (F); ns, non-significant;
��p<0.0021;
����p<0.0001. Scale bar = 1 mm.
G,H. S. sonnei is more virulent than S. flexneri in an intravenous infection model. Survival
curves (G) and Log10-transformed CFU counts (H) of larvae injected intravenously (IV, via
the duct of Cuvier) with PBS (grey), S. flexneri (blue) or S. sonnei (red). Experiments are cumu-
lative of 2 biological replicates. In H, full symbols represent live larvae and empty symbols rep-
resent larvae that at the plating timepoint had died within the last 16 hours. Statistics: Log-
rank (Mantel-Cox) test (G); ns, non-significant; ����p<0.0001.
I,J. A clinical isolate of S. sonnei is more virulent than a clinical isolate of S. flexneri. Sur-
vival curves (I) and Log10-transformed CFU counts (J) of larvae injected in the HBV with S.
flexneri isolate 2457T (blue) or S. sonnei isolate 381 (red). Experiments are cumulative of 3 bio-
logical replicates. In J, full symbols represent live larvae and empty symbols represent larvae
that at the plating timepoint had died within the last 16 hours. Statistics: Log-rank (Mantel-
Cox) test (I); unpaired t-test on Log10-transformed data (J);
��p<0.0021; ����p<0.0001.
K-N. S. sonnei is more virulent than S. flexneri at 32.5˚C and 37˚C. Survival curves (K,M)
and Log10-transformed CFU counts (L,N) of larvae injected in the HBV with PBS (grey), S.
flexneri (blue) or S. sonnei (red) at 32.5˚C (K,L) or at 37˚C (M,N). Experiments are cumulative
of 2 biological replicates. In L,N, full symbols represent live larvae and empty symbols repre-
sent larvae that at the plating timepoint had died within the last 16 hours. Due to increased vir-
ulence of S. sonnei at 32.5˚C (and poor survival of larvae at 24–72 hpi), CFU data are available
for< 3 larvae per biological replicate for some experimental groups. ND: not determined.
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Statistics: Log-rank (Mantel-Cox) test; ����p<0.0001.
(PDF)
S2 Fig. (Related to Fig 2) Whole animal dual-RNAseq profiling of S. sonnei infected larvae.
A,B. Principal component analysis (PCA) of S. sonnei and zebrafish larvae transcriptomes.
Analysis was performed on counts per million (CPM) reads values, using the dedicated PCA
tools in R. Individual biological replicates (R1, R2, R3) for control (blue) and infected (red)
conditions are reported. % in brackets indicate the variance of dimension explained by each
principal component. Plot in A refers to S. sonnei genes and plot in B refers to zebrafish genes.
C,D. Boxplots representing the distribution of reads within the RNAseq libraries of each
individual sample. Boxplots represent the sample median CPM reads with interquartile
range, while whiskers indicate the 2.5–97.5 percentile range. Control samples are indicated in
blue and infection samples are indicted in red. Biological replicates (R1, R2, R3) are also indi-
cated. Plot in C refers to S. sonnei gene libraries and plot in D refers to zebrafish gene libraries.
E-H. Distribution histograms of significantly differentially expressed genes in S. sonnei
and zebrafish larvae during infections. Each bar represents the number of significantly dif-
ferentially expressed genes (repressed, blue (E,F); induced, red (G,H)) in each interval of
Log2(FC). Plots in E,G refer to S. sonnei genes, while plots in F,H refer to zebrafish genes.
I. Induction of well-established inflammatory markers in the RNAseq transcriptome. Bars
indicate the average CPM reads for representative inflammatory marker. Compare to induc-
tion of same genes tested independently by qRT-PCR at the same timepoint in Fig 1D. Statis-
tics: unpaired t-test on Log2-transformed data;
��p<0.0021; ���p<0.0002; ����p< 0.0001.
J. Pathway enrichment analysis of S. sonnei during infection in vivo. Pathway enrichment
analysis was performed using eggNOG-mapper v2 to infer gene functions based on orthology.
% are relative to all genes bioinformatically annotated to the pathway of interest. A variety of
stress response processes are induced in S. sonnei in vivo in the zebrafish larvae, including
amino acid and lipid metabolism, response to pH and ion homeostasis. Fractions flanking the
histogram bars indicate the number of significantly affected genes in the pathway and the total
number of genes annotated to the pathway in the library of reference.
K. Pathway enrichment analysis of S. sonnei-infected zebrafish larvae. Pathway enrichment
analysis was performed using ShinyGO v0.60 (http://bioinformatics.sdstate.edu/go/). % are
relative to all the genes bioinformatically annotated to the pathway of interest. A variety of
immune-related processes are induced in zebrafish larvae in response to S. sonnei infection,
including leukocyte (especially neutrophil) chemotaxis, response to cytokines and inflamma-
tion. Fractions flanking the histogram bars indicate the number of significantly affected genes
in the pathway and the total number of genes annotated to the pathway in the library of refer-
ence.
(PDF)
S3 Fig. (Related to Fig 3) S. sonnei virulence depends on its O-antigen. A,B. Schematic of S.
sonnei and S. flexneri. Both S. flexneri and S. sonnei virulence plasmid encodes a type 3 secre-
tion system (T3SS). However, differently than S. flexneri, S. sonnei virulence plasmid (pSS)
encodes genes for the biosynthesis of a capsule and O-antigen (O-Ag) non-homologous to
those of other Escherichia and Shigella species. S. sonnei additionally encodes a type 6 secretion
system (T6SS) on the bacterial chromosome. The schematic in B also reports (in grey and
between brackets) the name of the mutants used in the study.
C,D. Virulence of S. sonnei in zebrafish does not depend on the T6SS or capsule. Survival
curves (C) and Log10-transformed CFU counts (D) of larvae injected in the HBV with S. sonnei
Δtssb (grey), Δg4c (blue), or WT (red) strains. Experiments are cumulative of 4 (C) or 3 (D)
biological replicates. In D, full symbols represent live larvae and empty symbols represent
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larvae that at the plating timepoint had died within the last 16 hours. Statistics: Log-rank
(Mantel-Cox) test (C); one-way ANOVA with Sidak’s correction on Log10-transformed data
(D); ns, non-significant.
E. S. sonnei virulence plasmid is maintained in vivo in zebrafish at 28.5˚C. Larvae were
injected with 1 nl (~7000 CFU) in the HBV with S. flexneri (blue) or S. sonnei (red) for 24 h at
28.5˚C. Control bacteria (TSA plates) were spotted onto tryptic soy agar plates (10 μl of the
bacterial inoculum/spot) and also grown for 24 h at 28.5˚C. Bacteria were then harvested from
larvae or plates and grown on Congo-Red plates at 37˚C to quantify colonies that lost the viru-
lence plasmid. Experiments are cumulative of 2 biological replicates. Statistics: one-way
ANOVA with Sidak’s correction; ns, non-significant; �p<0.0332; ��p<0.0021.
F. Comparison of S. sonnei and S. flexneri O-antigen. S. sonnei 53G O-antigen has a unique
sugar composition compared to the O-antigen of S. flexneri M90T. Figure legend abbrevia-
tions: AN: 2-Acetamido-2-deoxy-L-altruronic acid (L-AltNAc); FN: 2-Acetamido-4-amino-
2,4-dideoxy-D-fucose (D-FucNAc); GN: 2-Acetamido-2-deoxy-D-glucose (D-GlcNAc); R:
L-Rhamnose (L-Rha); G: D-Glucose (D-Glc); Ac: O-acetyl. Adapted from [56].
G. LPS blotting for S. sonnei strains used in this study. Crude LPS from WT, ΔO-Ag mutant,
ΔO-Ag mutant complemented with plasmidic S. sonnei O-Ag (ΔO-Ag+pSSO-Ag) and a stain
cured from the pSS virulence plasmid (-pSS) were run on a 12% SDS-PAGE gel and blotted
using an antibody specific to S. sonnei phase I O-Ag. Both the ΔO-Ag strain and the -pSS strain
do not express the O-Ag, and plasmid reintroduction of the O-Ag synthesis genes partly
restores O-Ag expression.
H-K. T3SS mutants and O-Ag mutants are attenuated in vivo at 32.5˚C. Survival curves (H,
J) and Log10-transformed CFU counts (I,K) of larvae injected in the HBV with ΔO-Ag (grey),
Δmxid (blue), or WT (red) S. sonnei at 32.5˚C with either ~2000 (H,I) or ~6000 (J,K) CFU.
Experiments are cumulative of 3 biological replicates. In I,K, full symbols represent live larvae
and empty symbols represent larvae that at the plating timepoint had died within the last 16
hours. Due to increased virulence of S. sonnei at 32.5˚C (and poor survival of larvae at 48–72
hpi) CFU data are available for< 3 larvae per biological replicate for some experimental
groups. ND: not determined. Statistics: Log-rank (Mantel-Cox) test (H,J); unpaired t-test on
Log10-transformed data (I,K);
����p< 0.0001.
L. Induction of the O-antigen chain length determinant protein wzzB in vivo. Dual-RNA-
seq profiling shows that the wzzB is significantly upregulated in S. sonnei infected zebrafish.
Bars indicate the average CPM reads. Statistics: unpaired t-test on Log2-transformed data;
���p<0.0002.
M. Bacterial replication is necessary for death of zebrafish larvae. Survival curves of larvae
injected in the HBV with heat killed ΔO-Ag (grey), heat killed WT (blue), live ΔO-Ag (green)
or live WT (red) S. sonnei. Experiments are cumulative of 3 biological replicates. Bacterial
input: ~6000 CFU. Statistics: Log-rank (Mantel-Cox) test; ns, non-significant; ����p<0.0001.
(PDF)
S4 Fig. (related to Fig 4) S. sonnei O-antigen can counteract clearance by zebrafish neutro-
phils. A-C. Chemical ablation of macrophages. Representative images (A,B) and quantifica-
tion (C) of macrophage ablation in Tg(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:nfsB.mCherry)c264
larvae which were treated with either Metronidazole (Mtz, macrophage ablated group, blue) or
control DMSO vehicle (DMSO, red) prior to infection in the HBV with S. sonnei. Experiments
are cumulative of 2 biological replicates. Statistics: two-tailed Mann-Whitney test;
����p<0.0001. Scale bars = 250 μm.
D,E. Macrophage ablation increases susceptibility to S. flexneri. Survival curves (D) and
Log10-transformed CFU counts (E) of Tg(mpeg1:Gal4-FF)gl25/Tg(UAS-E1b:nfsB.mCherry)c264
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larvae which were treated with either Metronidazole (Mtz, macrophage ablated group, blue) or
control DMSO vehicle (DMSO, red) prior to infection in the HBV with S. flexneri. Experi-
ments are cumulative of 3 biological replicates. In E, full symbols represent live larvae and
empty symbols represent larvae that at the plating timepoint had died within the last 16 hours.
Statistics: Log-rank (Mantel-Cox) test (D); unpaired t-test on Log10-transformed data (E); ns,
non-significant; �p<0.0332.
F-H. pu.1 morpholino knockdown results in neutrophil depletion. Representative images
(F,G) and quantification (H) of neutrophil depletion in Tg(lyz:dsRed)nz50 larvae injected with
pu.1 morpholino (blue) or control morpholino (red) at 1-cell stage. A significant ~3-fold
decrease in neutrophil number can be observed at 3 dpf, prior to infection in the HBV with S.
sonnei. Experiments are cumulative of 3 biological replicates. Statistics: two-tailed Mann-
Whitney test; ����p<0.0001. Scale bars = 250 μm.
I,J. pu.1 morpholino knockdown increases susceptibility to S. sonnei when infections are
performed at 30 hpf. Survival curves (I) and Log10-transformed CFU counts (J) of pu.1 mor-
phant (blue) or control (red) larvae infected in the HBV with WT S. sonnei. Experiments are
cumulative of 3 biological replicates. In J, full symbols represent live larvae and empty symbols
represent larvae that at the plating timepoint had died within the last 16 hours. To allow full
ablation of immune cells by morpholino knockdown, infections are performed at 30 hpf. Sta-
tistics: Log-rank (Mantel-Cox) test; ����p<0.0001.
(PDF)
S5 Fig. (related to Fig 5) S. sonnei can resist phagolysosome acidification and promote neu-
trophil cell death in an O-antigen-dependent manner. A,B. S. sonnei O-antigen contributes
to acid tolerance in vitro. Growth curves of ΔO-Ag (blue) or WT (red) S. sonnei, cultured in
tryptic soy broth adjusted to pH = 4 (A) or 6 (B). Statistics: unpaired t-test at the latest time-
point; ns, non-significant.
C. S. sonnei can replicate within phagosomes. Transmission electron micrograph of an
infected phagocyte from zebrafish larvae at 3 hpi with WT S. sonnei, showing a dividing S. son-
nei cell. Scale bar = 4 μm.
D. S. sonnei infection of zebrafish cell promotes morphological features of necrosis. Trans-
mission electron micrograph of an infected neutrophil from a zebrafish larva at 3 hpi with WT
S. sonnei, showing signs of necrotic cell death (arrowheads point at area of extranuclear chro-
matin degradation). Scale bar = 4 μm.
E. Pharmacological inhibition of necroptosis and/or apoptosis/pyroptosis does not protect
zebrafish larvae. Survival curves of larvae which were treated with Necrostatin-1 (grey),
Necrostatin-5 (blue), Q-VD-OPh (green), Necrostatin-1 + Q-VD-OPh (red) or control DMSO
vehicle (black) upon infection in the HBV with S. sonnei. Experiments are cumulative of 3 bio-
logical replicates. Bacterial input: ~7000 CFU. Statistics: Log-rank (Mantel-Cox) test; ns, non-
significant.
(PDF)
S6 Fig. (related to Fig 7) Innate immunity can be trained to control S. sonnei in vivo. A,B.
Response of 2dpf zebrafish embryos to sublethal dose (~80 CFU) of S. sonnei. Approxi-
mately 80% of WT GFP-S. sonnei injected embryos (and 100% of ΔO-Ag GFP-S. sonnei
injected embryos) control infection (no detectable bacteria by fluorescence microscopy) by 48
hpi (A). Log10-transformed CFU counts from controller larvae (no detectable bacteria by fluo-
rescence microscopy) infected in the HBV with GFP-ΔO-Ag (blue) or WT (red) S. sonnei.
Prior to receiving the secondary lethal dose (~8000 CFU) of mCherry-S. sonnei, ~80% of WT
GFP-S. sonnei injected controllers (and 100% of ΔO-Ag GFP-S. sonnei injected controllers)
cleared the primary infection (no CFU detectable from plating). Experiments are cumulative
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of 4 (A) or 3 (B) biological replicates. Statistics: two-sided chi-square contingency test;
����p<0.0001.
(PDF)
S1 Table. Differentially expressed S. sonnei genes and pathogen pathway enrichment anal-
ysis in vivo.
(XLSX)
S2 Table. Differentially expressed zebrafish genes and host pathway enrichment analysis
in response to S. sonnei infection.
(XLSX)
S3 Table. Bacterial strains used in this study.
(PDF)
S4 Table. Primers and morpholinos used in this study.
(PDF)
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